Sign up to access all our data and the evidence and analysis underlying our overall scores. Once you've created an account, we'll get in touch with further details:
Sign Up
| Overall Assessment |
Comment |
Score |
| None |
No evidence found.
|
0
|
| Overall Assessment |
Comment |
Score |
| None |
The evidence provided for 三生制药 does not disclose any governance processes or mechanisms specifically related to climate lobbying alignment. While it mentions the company's ESG management structure and its focus on climate change issues, including the role of the Board of Directors and ESG working groups in managing climate-related risks and opportunities, there is no reference to lobbying governance or alignment processes. Statements such as "三生制药建立了完善的ESG管理架构" and "由董事会统筹对公司气候变化相关事宜的管理" describe general climate governance but do not address lobbying activities or their alignment with climate goals. Additionally, the evidence discusses the company's efforts in greenhouse gas emissions measurement and climate risk analysis but does not provide any details on lobbying governance or oversight structures related to climate lobbying alignment. This indicates an absence of governance processes for climate lobbying alignment.
|
0
|